Tilray Brands, Inc. Common Stock (TLRY) — Analysis Summary
Tilray Brands, Inc. Common Stock (TLRY) has a market cap of $496.57M with year-over-year revenue growth of +11.5%. Net margin stands at -13.3%. The stock trades at a P/E ratio of -3.0.
Key Takeaways
- Revenue changed +11.5% year-over-year
- Net margin of -13.3%
- P/E ratio of -3.0
Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, TLRY posted revenue growth of +11.5% and trades at a P/E of -3.0.
Tilray Brands, Inc. Common Stock (TLRY)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Employees
3,595
Headquarters
NEW YORK, NY
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.